Gedeon Richter has become marketing authorisation holder for Evra, a once-weekly contraception for women of fertile age, which they say is the first and only transdermal contraceptive patch licenced in the UK.
Tamas Neubauer, Managing Director of UK and Ireland at Gedeon Richter, believes that the addition of a patch to their existing contraceptive delivery methods such as oral contraceptives, emergency contraceptives and their intra-uterine system, enables them to offer a wide selection of family planning solutions to women in the UK.
Neubauer said: “The acquisition emphasises our commitment to providing healthcare professionals and women with greater choice in contraception. As one of only a few companies in the world to offer a comprehensive gynaecological portfolio, we have years of experience in women’s healthcare and won’t rest until women can.”
